Advertisement
Screener

Perrigo Company plc (PRGO) Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax, Portion Attributable to Parent

Perrigo Company plc Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax, Portion Attributable to Parent

Perrigo Company plc (PRGO) reported Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax, Portion Attributable to Parent of -$9.40 million for the 3-month period ending 2020-03-28, per its 10-Q filed 2020-05-05.

Discontinued › Income Statement › Unrealized Gains

us-gaap:OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent · last filed 2021-03-01

  • Perrigo Company plc other comprehensive income (loss), derivatives qualifying as hedges, net of tax, portion attributable to parent for the quarter ending 2020-03-28 was -$9.40M, a 652.94% decline year-over-year.
  • Perrigo Company plc other comprehensive income (loss), derivatives qualifying as hedges, net of tax, portion attributable to parent for the quarter ending 2019-09-28 was $31.60M.
  • Perrigo Company plc other comprehensive income (loss), derivatives qualifying as hedges, net of tax, portion attributable to parent for the quarter ending 2019-06-29 was $2.70M.
  • Perrigo Company plc other comprehensive income (loss), derivatives qualifying as hedges, net of tax, portion attributable to parent for the quarter ending 2019-03-30 was $1.70M.
  • Perrigo Company plc other comprehensive income (loss), derivatives qualifying as hedges, net of tax, portion attributable to parent for fiscal 2018 was -$5.70M, a 158.76% decline from fiscal 2017.
  • Perrigo Company plc other comprehensive income (loss), derivatives qualifying as hedges, net of tax, portion attributable to parent for fiscal 2017 was $9.70M.
  • Perrigo Company plc other comprehensive income (loss), derivatives qualifying as hedges, net of tax, portion attributable to parent for fiscal 2016 was -$5.30M.
  • Perrigo Company plc other comprehensive income (loss), derivatives qualifying as hedges, net of tax, portion attributable to parent for fiscal 2015 was -$200.00K.
Period endOther Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax, Portion Attributable to Parent 3 monthOther Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax, Portion Attributable to Parent 3 month as first filedOther Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax, Portion Attributable to Parent 6 monthOther Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax, Portion Attributable to Parent 9 monthOther Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax, Portion Attributable to Parent 12 month
2020-03-28-$9.40M
10-Q · filed 2020-05-05
2019-09-28$31.60M
10-Q · filed 2019-11-06
$34.30M
derived: sum of 2 quarters · filed 2019-11-06
$36.00M
10-Q · filed 2019-11-06
$35.30M
derived: sum of 4 quarters · filed 2021-03-01
2019-06-29$2.70M
10-Q · filed 2019-08-08
$4.40M
10-Q · filed 2019-08-08
$3.70M
derived: sum of 3 quarters · filed 2021-03-01
$2.80M
derived: sum of 4 quarters · filed 2021-03-01
2019-03-30$1.70M
10-Q · filed 2020-05-05
$1.00M
derived: sum of 2 quarters · filed 2021-03-01
$100.00K
derived: sum of 3 quarters · filed 2021-03-01
-$3.40M
derived: sum of 4 quarters · filed 2021-03-01
2018-12-31-$700.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01
-$1.60M
derived: sum of 2 quarters · filed 2021-03-01
-$5.10M
derived: sum of 3 quarters · filed 2021-03-01
-$5.70M
10-K · filed 2021-03-01
2018-09-29-$900.00K
10-Q · filed 2019-11-06
-$4.40M
derived: sum of 2 quarters · filed 2019-11-06
-$5.00M
10-Q · filed 2019-11-06
-$4.00M
derived: sum of 4 quarters · filed 2020-02-27
2018-06-30-$3.50M
10-Q · filed 2019-08-08
-$4.10M
10-Q · filed 2019-08-08
-$3.10M
derived: sum of 3 quarters · filed 2020-02-27
-$3.00M
derived: sum of 4 quarters · filed 2020-02-27
2018-03-31-$600.00K
10-Q · filed 2019-05-09
$400.00K
derived: sum of 2 quarters · filed 2020-02-27
$500.00K
derived: sum of 3 quarters · filed 2020-02-27
$7.40M
derived: sum of 4 quarters · filed 2020-02-27
2017-12-31$1.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27
$1.10M
derived: sum of 2 quarters · filed 2020-02-27
$8.00M
derived: sum of 3 quarters · filed 2020-02-27
$9.70M
10-K · filed 2020-02-27
2017-09-30$100.00K
10-Q · filed 2018-11-08
$7.00M
derived: sum of 2 quarters · filed 2018-11-08
$8.70M
10-Q · filed 2018-11-08
$6.80M
derived: sum of 4 quarters · filed 2019-02-27
2017-07-01$6.90M
10-Q · filed 2018-08-09
$8.50M
10-Q · filed 2018-08-09
$6.70M
derived: sum of 3 quarters · filed 2019-02-27
$10.30M
derived: sum of 4 quarters · filed 2019-02-27
2017-04-01$1.60M
10-Q · filed 2018-05-08
-$200.00K
derived: sum of 2 quarters · filed 2019-02-27
$3.40M
derived: sum of 3 quarters · filed 2019-02-27
$2.10M
derived: sum of 4 quarters · filed 2019-02-27
2016-12-31-$1.80M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27
$1.80M
derived: sum of 2 quarters · filed 2019-02-27
$500.00K
derived: sum of 3 quarters · filed 2019-02-27
-$5.30M
10-K · filed 2019-02-27
2016-10-01$3.60M
10-Q · filed 2017-11-09
$2.30M
derived: sum of 2 quarters · filed 2017-11-09
-$3.50M
10-Q · filed 2017-11-09
-$1.40M
derived: sum of 4 quarters · filed 2018-03-01
2016-07-02-$1.30M
10-Q · filed 2017-08-10
-$7.00M
10-Q · filed 2017-08-10
-$5.00M
derived: sum of 3 quarters · filed 2018-03-01
-$4.90M
derived: sum of 4 quarters · filed 2018-03-01
2016-04-02-$5.70M
10-Q · filed 2017-05-30
-$3.70M
derived: sum of 2 quarters · filed 2018-03-01
-$3.60M
derived: sum of 3 quarters · filed 2018-03-01
$1.20M
derived: sum of 4 quarters · filed 2018-03-01
2015-12-31$2.00M
derived: 10-K 6 month − 10-Q/A 3 month · filed 2018-03-01
$2.10M
10-K · filed 2018-03-01
$6.90M
derived: sum of 3 quarters · filed 2018-03-01
$7.70M
derived: sum of 4 quarters · filed 2018-03-01
2015-09-26$100.00K
10-Q/A · filed 2017-05-23
$4.90M
derived: sum of 2 quarters · filed 2017-05-23
$5.60M
10-Q/A · filed 2017-05-23
$2.00M
derived: sum of 4 quarters · filed 2017-05-23
2015-06-27$4.80M
10-Q/A · filed 2017-05-22
$5.50M
10-Q/A · filed 2017-05-22
$1.90M
derived: sum of 3 quarters · filed 2017-05-22
-$200.00K
10-K · filed 2018-03-01
2015-03-28$800.00K
10-Q/A · filed 2017-05-22
-$2.90M
derived: sum of 2 quarters · filed 2017-05-22
-$5.00M
10-Q · filed 2015-04-29
-$5.00M
derived: sum of 4 quarters · filed 2017-05-22
2014-12-27-$3.70M
10-Q · filed 2015-02-05
-$5.80M
10-Q · filed 2015-02-05
-$5.80M
derived: sum of 3 quarters · filed 2017-05-22
-$6.80M
derived: sum of 4 quarters · filed 2017-05-22
2014-09-27-$2.10M
10-Q · filed 2015-11-02
-$2.10M
derived: sum of 2 quarters · filed 2017-05-22
-$3.10M
derived: sum of 3 quarters · filed 2017-05-22
-$4.50M
derived: sum of 4 quarters · filed 2017-05-22
2014-06-28$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2017-05-22
-$1.00M
derived: sum of 2 quarters · filed 2017-05-22
-$2.40M
derived: sum of 3 quarters · filed 2017-05-22
-$11.60M
10-K · filed 2017-05-22
2014-03-29-$1.00M
10-Q · filed 2015-04-29
-$2.40M
derived: sum of 2 quarters · filed 2015-04-29
-$11.60M
10-Q · filed 2015-04-29
-$13.90M
derived: sum of 4 quarters · filed 2016-02-25
2013-12-28-$1.40M
10-Q · filed 2015-02-05
-$10.60M
10-Q · filed 2015-02-05
-$12.90M
derived: sum of 3 quarters · filed 2016-02-25
-$11.30M
derived: sum of 4 quarters · filed 2016-02-25
2013-09-28-$9.20M
8-K · filed 2014-11-20
-$16.51M
10-Q · filed 2013-11-04
-$11.50M
derived: sum of 2 quarters · filed 2016-02-25
-$9.90M
derived: sum of 3 quarters · filed 2016-02-25
-$4.70M
derived: sum of 4 quarters · filed 2016-02-25
2013-06-29-$2.30M
derived: 10-KT 12 month − 10-Q 9 month · filed 2016-02-25
-$700.00K
derived: sum of 2 quarters · filed 2016-02-25
$4.50M
derived: sum of 3 quarters · filed 2016-02-25
$6.00M
10-KT · filed 2016-02-25
2013-03-30$1.60M
10-Q · filed 2014-05-07
$6.80M
derived: sum of 2 quarters · filed 2014-05-07
$8.30M
10-Q · filed 2014-05-07
2012-12-29$5.20M
10-Q · filed 2014-02-06
$6.70M
10-Q · filed 2014-02-06
2012-06-30-$9.40M
10-K · filed 2014-08-14

Similar stocks

Stock NameCountryMarket CapPE Ratio
NEKTAR THERAPEUTICS (NKTR)United States$2.026B-9.05
Generate Biomedicines, Inc. (GENB)United States$2.052B
UroGen Pharma Ltd. (URGN)$2.015B-18.42
Nuvation Bio Inc. (NUVB)United States$2.007B-13.12
Biohaven Ltd. (BHVN)United States$1.990B-3.83
Trevi Therapeutics, Inc. (TRVI)United States$2.091B-51.93
PALVELLA THERAPEUTICS, INC. (PVLA)United States$2.105B-35.55
Braveheart Bio, Inc. (BRVE)United States$2.106B
Bausch Health Companies Inc. (BHC)$2.113B-1.68
AGIOS PHARMACEUTICALS, INC. (AGIO)United States$1.962B-5.38